Bone Growth Stimulators - Global Market Trajectory & Analytics

Global Bone Growth Stimulators Market to Reach US$ 1.3 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Bone Growth Stimulators estimated at US$ 999.4 Million in the year 2020, is projected to reach a revised size of US$ 1.3 Billion by 2027, growing at a CAGR of 4.2% over the analysis period 2020-2027.Stimulation Devices, one of the segments analyzed in the report, is projected to grow at a 4.3% CAGR to reach US$ 739 Million by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bone Morphogenetic Proteins (bmp) segment is readjusted to a revised 3.8% CAGR for the next 7-year period. This segment currently accounts for a 35.1% share of the global Bone Growth Stimulators market.

The U.S. Accounts for Over 51.3% of Global Market Size in 2020, While China is Forecast to Grow at a 6.1% CAGR for the Period of 2020-2027

The Bone Growth Stimulators market in the U.S. is estimated at US$ 513 Million in the year 2020. The country currently accounts for a 51.34% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$ 89.5 Million in the year 2027 trailing a CAGR of 6.1% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 3.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR while Rest of European market (as defined in the study) will reach US$ 89.5 Million by the year 2027.

Platelet-Rich Plasma (PRP) Segment Corners a 9.8% Share in 2020

In the global Platelet-Rich Plasma (PRP) segment, USA, Canada, Japan, China and Europe will drive the 4.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$ 81.2 Million in the year 2020 will reach a projected size of US$ 111.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$ 96.2 Million by the year 2027, while Latin America will expand at a 6% CAGR through the analysis period. The publisher brings years of research experience to this 6th edition of the report. The 380-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Select Competitors (Total 62 Featured):

• Arthrex, Inc.
• Bioventus LLC
• DePuy Synthes
• DJO Global, Inc.
• ISTO Biologics
• Medtronic PLC
• Stryker Corporation
• Terumo BCT, Inc.
• Zimmer Biomet Holdings, Inc.